Hyperventilation in Patients With Traumatic Brain Injury
Effects of Moderate Hyperventilation on Cerebral Hemodynamics, Oxygenation and Metabolism in Patients With Severe Traumatic Brain Injury
1 other identifier
interventional
11
1 country
1
Brief Summary
Elevated intracranial pressure is a dangerous and potentially fatal complication after traumatic brain injury. Hyperventilation is a medical intervention to reduce elevated intracranial pressure by inducing cerebral vasoconstriction, which might be associated to cerebral ischemia and hypoxia. The main hypothesis is that a moderate degree of hyperventilation is sufficient to reduce the intracranial pressure without inducing cerebral ischemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2017
CompletedFirst Submitted
Initial submission to the registry
January 22, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedJanuary 30, 2019
January 1, 2019
3 years
January 22, 2019
January 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
intracranial pressure
Change of intracranial pressure during moderate hyperventilation
10, 20, 50, 60 minutes after begin of the hyperventilation test
Secondary Outcomes (3)
cerebral flow velocity in the middle cerebral artery
20, 50, 60 minutes after begin of the hyperventilation test
brain tissue oxygenation (PbrO2)
10, 20, 50, 60 minutes after begin of the hyperventilation test
cerebral Lactate/ Pyruvate ratio
1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test
Study Arms (1)
patients with severe TBI
OTHERPatients with severe TBI enrolled in the study undergo an hyperventilation test, in which the alveolar ventilation is increased by a stepwise increase in tidal volumes and respiratory rate until a reduction of etCO2 of 0.7 kPa is achieved.
Interventions
Increase of the alveolar ventilation by a stepwise increase in tidal volumes and respiratory rate until a reduction of end-tidal CO2 of 0.7 kPa is achieved
Eligibility Criteria
You may qualify if:
- nonpenetrating traumatic brain injury
- Glasgow coma scale \<9 at presentation
- Intracranial pressure monitoring
- brain tissue oxygen tension monitoring and/or microdialysis monitoring
- invasive mechanical ventilation with FIO2 \<60% and PEEP \<15 mbar
You may not qualify if:
- decompressive craniectomy
- pregnancy
- pre-existing neurological disease
- previous traumatic brain injury
- acute cardiovascular disease
- severe respiratory failure
- acute on chronic liver disease
- sepsis
- failure to obtain satisfactory bilateral TCCD signals
- persisting hypovolemia or hemodynamic instability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Zurich
Zurich, 8006, Switzerland
Related Publications (2)
Klinzing S, Stretti F, Pagnamenta A, Bechir M, Brandi G. Transcranial color-coded duplex sonography assessment of cerebrovascular reactivity to carbon dioxide: an interventional study. BMC Neurol. 2021 Aug 7;21(1):305. doi: 10.1186/s12883-021-02310-9.
PMID: 34364365DERIVEDBrandi G, Stocchetti N, Pagnamenta A, Stretti F, Steiger P, Klinzing S. Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury. Crit Care. 2019 Feb 13;23(1):45. doi: 10.1186/s13054-018-2304-6.
PMID: 30760295DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Steiger, MD
University of Zurich
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2019
First Posted
January 30, 2019
Study Start
May 20, 2014
Primary Completion
May 2, 2017
Study Completion
May 2, 2017
Last Updated
January 30, 2019
Record last verified: 2019-01